HRNR and neoplasm: Hornerin was recently shown to be highly expressed by pancreatic tumor endothelium; to alter tumor vessel parameters through a VEGF-independent mechanism [26]; and to promote tumor progression in human tissues and in cell models of hepatocellular carcinoma [27].